MODULE 1 HIV: prevention, diagnosis, and treatment. Part 4 - Treatment and DDIs
Course author
Obsidian Healthcare Group
We are a full-service, global Group delivering exceptional healthcare communications and independent medical education
Course overview
Tailoring ART regimens for each individual is essential in ensuring optimal treatment. This course will cover factors to consider when selecting ART regimens, including patient comorbidities, drug-drug interactions, and HIV viral load and variant. The course is part of the “Test My Knowledge: HIV” program, providing bite-sized elearning for healthcare professionals who treat or come into contact with people living with HIV, from hospital doctors or nurses to general physicians and programme managers. The programme was created by three leading international experts in HIV – Professor Dr Jürgen Rockstroh (Germany), Dr Nittaya Phanuphak (Thailand) and Dr Tristan Barber (United Kingdom) – to improve knowledge of HIV in the treatment community, combat stigma and improve patient outcomes. This programme was funded through an unrestricted educational grant from Gilead. The sponsor had no influence on the selection of the scientific committee or topics, or on the creation of any content.
What you will learn
- When to initiate ART treatment
- The favorable and unfavorable effects of the M184V mutation for PLWH
- The risks associated with the use of PIs
- The difference between HIV-1 and HIV-2
- The difference between first- and second-generation NNRTIs
- Factors to consider when selecting ART regimens for individuals with polypharmacy, comorbidities or swallowing difficulties
The full course includes
- About this course
- ART initiation
- Abacavir
- M184V
- PIs
- NNRTI
- INSTIs
- HIV-2
- Drug-drug interactions
- Hepatic and renal impairments
- Prescribing in elderly PLWH
- ART in persons with swallowing difficulties
- Final quiz